Guizhou Yibai Pharmaceutical Co Ltd Cash Flow Reinvestment Rate
Guizhou Yibai Pharmaceutical Co Ltd cash flow reinvestment rate. Guizhou Yibai Pharmaceutical Co Ltd (600594) has a Cash Flow Reinvestment Rate of 0.21x as of September 2025, reinvesting CN¥7.08 Million (capex CN¥7.08 Million ) from operating cash flow of CN¥33.28 Million. Explore 600594 cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Guizhou Yibai Pharmaceutical Co Ltd (2002–2025)
Cash flow reinvestment rate of Guizhou Yibai Pharmaceutical Co Ltd from 2002 to 2025. Historical reinvestment intensity for Guizhou Yibai Pharmaceutical Co Ltd across 23 annual periods. Explore reinvestment intensity of Guizhou Yibai Pharmaceutical Co Ltd to see what proportion of operating cash flow is directed to capital expenditures.
Guizhou Yibai Pharmaceutical Co Ltd Cash Flow Reinvestment Rate by Year (2002–2025)
Guizhou Yibai Pharmaceutical Co Ltd cash flow reinvestment rate by year from 2002 to 2025. Year-by-year capital reinvestment analysis for Guizhou Yibai Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see Guizhou Yibai Pharmaceutical Co Ltd cash flow conversion.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.14x | CN¥35.08 Million | CN¥256.71 Million | CN¥34.99 Million | ▼ -89.8% |
| 2024 | 1.34x | CN¥116.31 Million | CN¥86.87 Million | CN¥96.32 Million | ▲ +286.6% |
| 2023 | 0.35x | CN¥130.78 Million | CN¥377.61 Million | CN¥130.38 Million | ▼ -65.1% |
| 2022 | 0.99x | CN¥342.92 Million | CN¥345.30 Million | CN¥322.92 Million | ▲ +69.2% |
| 2021 | 0.59x | CN¥548.48 Million | CN¥934.21 Million | CN¥447.78 Million | ▼ -56.5% |
| 2020 | 1.35x | CN¥494.68 Million | CN¥366.66 Million | CN¥395.74 Million | ▲ +142.1% |
| 2019 | 0.56x | CN¥202.17 Million | CN¥362.71 Million | CN¥201.28 Million | ▼ -62.9% |
| 2018 | 1.50x | CN¥322.01 Million | CN¥214.30 Million | CN¥321.33 Million | ▲ +124.1% |
| 2017 | 0.67x | CN¥457.21 Million | CN¥681.78 Million | CN¥402.80 Million | ▼ -31.6% |
| 2016 | 0.98x | CN¥373.22 Million | CN¥380.62 Million | CN¥332.53 Million | ▲ +95.3% |
| 2015 | 0.50x | CN¥288.02 Million | CN¥573.68 Million | CN¥288.02 Million | ▲ +33.3% |
| 2014 | 0.38x | CN¥203.94 Million | CN¥541.58 Million | CN¥203.94 Million | ▼ -20.5% |
| 2013 | 0.47x | CN¥273.48 Million | CN¥577.24 Million | CN¥273.48 Million | ▼ -34.9% |
| 2012 | 0.73x | CN¥209.64 Million | CN¥288.01 Million | CN¥209.64 Million | ▲ +42.1% |
| 2011 | 0.51x | CN¥142.34 Million | CN¥277.83 Million | CN¥142.34 Million | ▲ +19.3% |
| 2010 | 0.43x | CN¥49.66 Million | CN¥115.66 Million | CN¥49.66 Million | ▼ -0.1% |
| 2009 | 0.43x | CN¥44.62 Million | CN¥103.88 Million | CN¥44.62 Million | ▲ +29.3% |
| 2008 | 0.33x | CN¥62.86 Million | CN¥189.26 Million | CN¥62.86 Million | ▼ -89.8% |
| 2007 | 3.26x | CN¥38.97 Million | CN¥11.94 Million | CN¥38.97 Million | ▲ +1738.0% |
| 2006 | 0.18x | CN¥17.00 Million | CN¥95.77 Million | CN¥17.00 Million | ▼ -96.2% |
| 2005 | 4.66x | CN¥80.99 Million | CN¥17.38 Million | CN¥80.99 Million | ▲ +153.2% |
| 2003 | 1.84x | CN¥169.47 Million | CN¥92.10 Million | CN¥169.47 Million | ▲ +501.0% |
| 2002 | 0.31x | CN¥22.49 Million | CN¥73.46 Million | CN¥22.49 Million | — |